29.5 USD
+0.19 (+0.65%)
Taking everything into account, TCMD scores 6 out of 10 in our fundamental rating. TCMD was compared to 184 industry peers in the Health Care Equipment & Supplies industry. TCMD has an excellent financial health rating, but there are some minor concerns on its profitability. TCMD is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes TCMD very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year TCMD was profitable.
In the past year TCMD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TCMD reported negative net income in multiple years.
Each year in the past 5 years TCMD had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.01%, TCMD belongs to the top of the industry, outperforming 88.04% of the companies in the same industry.
TCMD has a better Return On Equity (8.86%) than 82.07% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.56%, TCMD belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROIC | 7.56% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TCMD's Profit Margin of 5.83% is fine compared to the rest of the industry. TCMD outperforms 78.26% of its industry peers.
TCMD's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 7.39%, TCMD is in the better half of the industry, outperforming 72.83% of the companies in the same industry.
TCMD's Operating Margin has improved in the last couple of years.
TCMD has a Gross Margin (49.88%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TCMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
TCMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TCMD has been increased compared to 1 year ago.
The number of shares outstanding for TCMD has been increased compared to 5 years ago.
Compared to 1 year ago, TCMD has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 9.45 indicates that TCMD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.45, TCMD belongs to the best of the industry, outperforming 89.67% of the companies in the same industry.
TCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.45 |
ROIC/WACC0.87
WACC8.68%
2.3 Liquidity
TCMD has a Current Ratio of 3.61. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.61, TCMD is doing good in the industry, outperforming 61.96% of the companies in the same industry.
TCMD has a Quick Ratio of 3.20. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
TCMD's Quick ratio of 3.20 is fine compared to the rest of the industry. TCMD outperforms 66.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 |
3. Growth
3.1 Past
TCMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
The Earnings Per Share has been growing slightly by 4.86% on average over the past years.
The Revenue has grown by 9.28% in the past year. This is quite good.
The Revenue has been growing by 9.11% on average over the past years. This is quite good.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
3.2 Future
Based on estimates for the next years, TCMD will show a very strong growth in Earnings Per Share. The EPS will grow by 20.90% on average per year.
Based on estimates for the next years, TCMD will show a quite strong growth in Revenue. The Revenue will grow by 8.94% on average per year.
EPS Next Y14.64%
EPS Next 2Y19.86%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 38.31 indicates a quite expensive valuation of TCMD.
TCMD's Price/Earnings ratio is a bit cheaper when compared to the industry. TCMD is cheaper than 70.65% of the companies in the same industry.
TCMD's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.61.
A Price/Forward Earnings ratio of 28.92 indicates a quite expensive valuation of TCMD.
Based on the Price/Forward Earnings ratio, TCMD is valued a bit cheaper than 72.28% of the companies in the same industry.
TCMD's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.31 | ||
| Fwd PE | 28.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TCMD is valued a bit cheaper than the industry average as 78.26% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, TCMD is valued cheaply inside the industry as 92.93% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.73 | ||
| EV/EBITDA | 18.79 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TCMD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as TCMD's earnings are expected to grow with 20.90% in the coming years.
PEG (NY)2.62
PEG (5Y)7.88
EPS Next 2Y19.86%
EPS Next 3Y20.9%
5. Dividend
5.1 Amount
TCMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:TCMD (12/23/2025, 3:48:46 PM)
29.5
+0.19 (+0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners98.46%
Inst Owner Change-2.68%
Ins Owners2.66%
Ins Owner Change-0.47%
Market Cap659.03M
Revenue(TTM)311.51M
Net Income(TTM)18.17M
Analysts81.82
Price Target24.48 (-17.02%)
Short Float %8.55%
Short Ratio4.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.96%
Min EPS beat(2)27.09%
Max EPS beat(2)102.84%
EPS beat(4)3
Avg EPS beat(4)18.21%
Min EPS beat(4)-82.07%
Max EPS beat(4)102.84%
EPS beat(8)7
Avg EPS beat(8)30.85%
EPS beat(12)11
Avg EPS beat(12)304.86%
EPS beat(16)11
Avg EPS beat(16)169.54%
Revenue beat(2)2
Avg Revenue beat(2)5.32%
Min Revenue beat(2)4.63%
Max Revenue beat(2)6.01%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)6.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)6
Avg Revenue beat(12)0.51%
Revenue beat(16)10
Avg Revenue beat(16)1.53%
PT rev (1m)42.57%
PT rev (3m)77.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)29.13%
EPS NY rev (3m)26.27%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.99%
Revenue NY rev (1m)2.44%
Revenue NY rev (3m)2.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.31 | ||
| Fwd PE | 28.92 | ||
| P/S | 2.12 | ||
| P/FCF | 16.73 | ||
| P/OCF | 15.75 | ||
| P/B | 3.22 | ||
| P/tB | 4.92 | ||
| EV/EBITDA | 18.79 |
EPS(TTM)0.77
EY2.61%
EPS(NY)1.02
Fwd EY3.46%
FCF(TTM)1.76
FCFY5.98%
OCF(TTM)1.87
OCFY6.35%
SpS13.94
BVpS9.17
TBVpS5.99
PEG (NY)2.62
PEG (5Y)7.88
Graham Number12.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROCE | 10.46% | ||
| ROIC | 7.56% | ||
| ROICexc | 11.94% | ||
| ROICexgc | 24.41% | ||
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% | ||
| FCFM | 12.65% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 36.37% | ||
| Cap/Sales | 0.79% | ||
| Interest Coverage | 17.31 | ||
| Cash Conversion | 140.64% | ||
| Profit Quality | 216.85% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 | ||
| Altman-Z | 9.45 |
F-Score7
WACC8.68%
ROIC/WACC0.87
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
EPS Next Y14.64%
EPS Next 2Y19.86%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
EBIT growth 1Y7.23%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year85.47%
EBIT Next 3Y35.54%
EBIT Next 5YN/A
FCF growth 1Y99.58%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y95.92%
OCF growth 3Y149.11%
OCF growth 5Y74.54%
TACTILE SYSTEMS TECHNOLOGY I / TCMD FAQ
Can you provide the ChartMill fundamental rating for TACTILE SYSTEMS TECHNOLOGY I?
ChartMill assigns a fundamental rating of 6 / 10 to TCMD.
What is the valuation status for TCMD stock?
ChartMill assigns a valuation rating of 5 / 10 to TACTILE SYSTEMS TECHNOLOGY I (TCMD). This can be considered as Fairly Valued.
What is the profitability of TCMD stock?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a profitability rating of 6 / 10.
What are the PE and PB ratios of TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
The Price/Earnings (PE) ratio for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 38.31 and the Price/Book (PB) ratio is 3.22.
Can you provide the financial health for TCMD stock?
The financial health rating of TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 8 / 10.